Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1971 Jun;25(2):306–310. doi: 10.1038/bjc.1971.39

Mithramycin Treatment of Hypercalcaemia and Renal Failure in a Patient with Paratesticular Embryonic Sarcoma

V Parsons, G Scott, M Baum, E Molland, J Makin
PMCID: PMC2008444  PMID: 4256008

Abstract

A 17-year-old patient with a small paratesticular embryonic sarcoma presented with symptoms of renal failure, polyuria and widespread bone metastases. Investigation revealed hypercalcaemia and uraemia without any evidence of hyperparathyroidism. The hypercalcaemia responded over a period of weeks to administration of mithramycin with initial improvement in the symptoms and metabolic derangements. Control was lost with the necrosis of intra-abdominal tumour deposits and haemorrhagic polypoid deposits in the alimentary tract. The value and hazards of mithramycin are well demonstrated by these rare complications of this type of tumour.

Full text

PDF
308

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWN J. H., KENNEDY B. J. MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS. N Engl J Med. 1965 Jan 21;272:111–118. doi: 10.1056/NEJM196501212720301. [DOI] [PubMed] [Google Scholar]
  2. Edwards C. R., Besser G. M. Mithramycin treatment of malignant hypercalcaemia. Br Med J. 1968 Jul 20;3(5611):167–168. doi: 10.1136/bmj.3.5611.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kennedy B. J., Griffen W. O., Jr, Lober P. Specific effect of mithramycin on embryonal carcinoma of the testis. Cancer. 1965 Dec;18(12):1631–1636. doi: 10.1002/1097-0142(196512)18:12<1631::aid-cncr2820181216>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  4. PATTON R. B., HORN R. C., Jr Rhabdomyosarcoma: clinical and pathological features and comparison with human fetal and embryonal skeletal muscle. Surgery. 1962 Oct;52:572–584. [PubMed] [Google Scholar]
  5. Parsons V., Baum M., Self M. Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease. Br Med J. 1967 Feb 25;1(5538):474–477. doi: 10.1136/bmj.1.5538.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ream N. W., Perlia C. P., Wolter J., Taylor S. G., 3rd Mithramycin therapy in disseminated germinal testicular cancer. JAMA. 1968 Jun 17;204(12):1030–1036. [PubMed] [Google Scholar]
  7. Sherwood L. M., O'Riordan J. L., Aurbach G. D., Potts J. T., Jr Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab. 1967 Jan;27(1):140–146. doi: 10.1210/jcem-27-1-140. [DOI] [PubMed] [Google Scholar]
  8. Singer F. R., Neer R. M., Murray T. M., Keutmann H. T., Deftos L. J., Potts J. T., Jr Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma. N Engl J Med. 1970 Sep 17;283(12):634–636. doi: 10.1056/NEJM197009172831206. [DOI] [PubMed] [Google Scholar]
  9. Yarbro J. W., Kennedy B. J., Barnum C. P. Mithramycin inhibition of ribonucleic acid synthesis. Cancer Res. 1966 Jan;26(1):36–39. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES